A Major Leap Forward For Drug Development? How BullFrog's AI Platform Is Driving Research Forward

Vin Singh, Founder & CEO of BullFrog AI BFRGW, was recently interviewed by Benzinga.

BullFrog AI is a technology company offering its bfLEAP platform, transforming the field of precision medicine. The platform applies predictive analytics to all stages of drug development to create novel therapies faster – potentially revolutionizing drug development.

The company has partnered with one of the most prestigious research institutions in the world, Johns Hopkins University, to license its AI technology.

Learn more here:

Featured photo by Louis Reed on Unsplash.

This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.